BISTTRY12:36Live
MEDTR Balance Sheet and Financial StatementsMeditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
19.10−0.52 (−2.65%)
- Volume
- TRY 1.5M
- Day range
- 19.10 – 19.78
- Previous close
- 19.62
- Market cap
- TRY 2.3B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for MEDTR is 2026/6. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. (MEDTR), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/6 | 713.8M | 92.3M | −23.2M |
| 2026/3 | 646.2M | 52.3M | −55M |
| 2025/12 | 875.3M | 71.8M | 64M |
| 2025/9 | 339.2M | 27.4M | 49M |
| 2025/6 | 873.4M | 114.7M | −32.3M |
Frequently Asked Questions
How much profit did MEDTR report in its latest statements?
In the latest period (2026/6) MEDTR reported a net profit of TRY −23.2M, sales of TRY 713.8M and EBITDA of TRY 92.3M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.